The kinds of skills needed to make artificial intelligence work in the real economy may be closer to plumbing than rocket science, say experts at Science|Business roundtable
In October 2016, the Science|Network of universities, companies and innovation organisations gathered in Brussels to debate the future of EU R&D programmes. The result: A profusion of ideas, recommendations and warnings for the future of EU research and innovation.
In this report, for presentation to the Commissioner at the annual Science|Business Horizon 2020 conference on 16 February 2016 in Brussels, we suggest that an EIC focus on two fundamental problems: encouraging more breakthrough innovations, and scaling them up quickly within Europe and beyond. This requires tackling many sub-issues: market barriers, funding shortfalls, skills gaps, poor visibility, uncoordinated policies. But if we are to go through the political effort of creating a new agency – or deciding not to do so – there should be a clear, simple objective. In just four words: scale up breakthrough innovations.
This report explores the effectiveness of Finland’s high-growth entrepreneurship policy: whether or not this policy has helped mitigate money and skills gaps in the Finnish entrepreneurial ecosystem, thereby helping new firms grow.
Across the European Union, healthcare authorities are striving to increase the efficiency and effectiveness of their delivery systems. The population is ageing; technology is advancing; costs are rising; and people’s expectations about healthcare are changing. Horizon 2020, the EU’s flagship research and innovation programme, can help deal with these challenges – in fact, member-states are demanding it do so.
Every year since 2008, the Science|Business Innovation Board has gathered entrepreneurs and innovators from across Europe for its annual awards. Meet this year’s winners – transforming education, enterprise, and the economy.
Advocates for cross-sectoral R&D support fear a downgrade in the new Commission – but in individual areas such as energy, digital technologies, and pharmaceuticals, a stronger emphasis on growth and investment is good news for many
